Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0096 | N/A |
Market Cap | $103.01K | N/A |
Shares Outstanding | 10.73M | N/A |
Employees | 35.00 | N/A |